US Broker Ratings

Amgen Inc. (AMGN) Stock Analysis: Solid Dividend Yield and Strong ROE Highlight Investment Appeal

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, remains a compelling option for investors seeking stability and income in the drug manufacturing industry. With a market capitalization of..

Stryker Corporation (SYK): Investor Outlook with a 14.83% Potential Upside

Stryker Corporation (NYSE: SYK), a titan in the medical devices industry, presents a compelling case for investors seeking growth in the healthcare sector. With a robust market capitalization of $144.06..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a 18.08% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare plans industry, is capturing investor attention with its promising potential upside of 18.08%. This established health benefits company, formerly known..

UnitedHealth Group (UNH) Stock Analysis: Consistent Growth in Healthcare with a 2.63% Dividend Yield for Investors

As one of the titans in the healthcare sector, UnitedHealth Group Incorporated (NYSE: UNH) stands out not just for its impressive market capitalization of $304.93 billion, but also for its..

BeOne Medicines Ltd. (ONC) Investor Outlook: Strong Buy Ratings Signal Promising Upside Potential

For investors eyeing opportunities in the healthcare sector, BeOne Medicines Ltd. (ONC) presents an intriguing proposition. The Swiss-based biotechnology company, with a formidable market cap of $39 billion, is making..

Zoetis Inc. (ZTS) Stock Analysis: A Compelling 30% Upside in the Expanding Animal Health Sector

Investors looking to capitalize on the growth of the animal health sector should eye Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare industry with a robust portfolio of..

Gilead Sciences, Inc. (GILD) Stock Analysis: Key Metrics and Growth Potential for Investors

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector with a robust market capitalization of approximately $141.56 billion, continues to pique the interest of investors looking to tap..

IQVIA Holdings, Inc. (IQV)

⚠️ No article content returned.

..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 20% Potential Upside with Strategic Investments

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to draw investor attention with its robust portfolio and strategic partnerships. Despite the current economic turbulence, Pfizer’s market positioning..

Medtronic plc (MDT) Stock Analysis: Navigating Healthcare Growth with a 3.73% Upside

Medtronic plc (NYSE: MDT), a titan in the medical devices industry with a formidable market cap of $121.96 billion, continues to attract attention from investors looking to capitalize on growth..

McKesson Corporation (MCK) Stock Analysis: Exploring a 12.93% Upside in the Healthcare Giant

Investors looking for robust opportunities in the healthcare sector might find McKesson Corporation (NYSE: MCK) a compelling choice. With a market capitalization of $86.86 billion, McKesson stands as a formidable..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 21% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, has been capturing the attention of investors with a compelling potential upside of 21.06%. Headquartered in Tokyo, Japan,..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Leader with 4.91% Potential Upside

Abbott Laboratories (NYSE: ABT) stands as a prominent player in the healthcare sector, boasting a significant market presence with a capitalization of $236.77 billion. Founded in 1888 and based in..

Johnson & Johnson (JNJ) Investor Outlook: Analyzing a $424 Billion Healthcare Giant’s Growth and Dividend Potential

Johnson & Johnson (NYSE: JNJ) stands as a formidable pillar in the healthcare industry, commanding a market capitalization of $424.33 billion. As an integral player in the Drug Manufacturers –..

Novo Nordisk A/S (NVO) Stock Analysis: Assessing Growth and Dividend Potential in a Dynamic Healthcare Market

Novo Nordisk A/S (NYSE: NVO) stands as a titan in the healthcare sector, with an impressive market capitalization of $272.72 billion. Operating primarily in the drug manufacturing industry, the Danish..

Novartis AG (NVS) Stock Analysis: Navigating the Healthcare Giant’s 15.3% Revenue Growth Amid Market Volatility

Novartis AG (NYSE: NVS), a titan in the healthcare sector, commands attention with its robust market capitalization of $238.79 billion. Headquartered in Basel, Switzerland, Novartis operates on a global scale,..

Kamada Ltd. (KMDA) Stock Analysis: Exploring the 101% Potential Upside and Growth Prospects

Kamada Ltd. (NASDAQ: KMDA), an established player in the specialty and generic drug manufacturing sector, has been capturing the attention of investors with its impressive 101% potential upside, according to..

Celcuity Inc. (CELC) Stock Analysis: A Biotech Innovator with 26.16% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a dynamic player in the biotechnology sector, has caught the attention of the investment community with its cutting-edge approach to cancer treatment and an impressive market..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Powerhouse with 139% Upside Potential

ATAI Life Sciences N.V. (NASDAQ: ATAI) is making waves in the biotechnology sector with its innovative approach to mental health treatment. Headquartered in Amstelveen, Netherlands, ATAI is a clinical-stage biopharmaceutical..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 65.76% Potential Upside for Investors

AngioDynamics, Inc. (NASDAQ: ANGO) is positioned as a compelling player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $447.38 million, AngioDynamics..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds